61570-10 Lipitor (Master)
ثبت نشده
چکیده
Lipitor tablets for oral administration contain 10, 20, 40 or 80 mg atorvastatin and the following inactive ingredients: calcium carbonate, USP; candelilla wax, FCC; croscarmellose sodium, NF; hydroxypropyl cellulose, NF; lactose monohydrate, NF; magnesium stearate, NF; microcrystalline cellulose, NF; Opadry White YS-1-7040 (hypromellose, polyethylene glycol, talc, titanium dioxide); polysorbate 80, NF; simethicone emulsion.
منابع مشابه
Profiting from innovations: the role of new game strategies in the case of Lipitor of the US pharmaceutical industry
In exploring why innovators often do not profit from their innovations, researchers concentrate on innovators versus imitators and the extent to which owners of complementary assets capture profits from innovations. The literature provides scant attention to factors that sap profits from innovations. This paper argues that an innovator’s positioning vis-à-vis customers, suppliers, complementors...
متن کاملThe top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.
Antipsychotics and Antidepressants Once Again Lead CNS Therapeutics D for the top prescription drugs of 2011 in the Unites States was recently released by IMS Health, and as we have done each year, we will break down the key stats as they apply to CNS therapeutics. Total prescription drug sales in the United States increased from $308.6 billion in 2010 to $319.9 billion in 2011 (an ∼3.5% increa...
متن کاملComparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized with an Acute Coronary Syndrome
BACKGROUND Although generic medications are approved based on bioequivalence with brand-name medications, there remains substantial concern regarding their clinical effectiveness and safety. Lipitor(®), available as generic atorvastatin, is one of the most commonly prescribed statins. Therefore, we compared the effectiveness of generic atorvastatin products and Lipitor(®). METHODS AND RESULTS...
متن کاملA Structural Model of Correlated Learning and Late-Mover Advantages: The Case of Statins
When Lipitor entered the statin (a class of anti-cholesterol drugs) market in 1997, some incumbent drugs had already obtained strong clinical evidence to show their efficacy in preventing heart diseases. Although it lacked such important evidence, Lipitor quickly became the most commonly used statin among new patients. To explain this puzzle, we propose a theory of correlated learning and indir...
متن کاملStatins and Adverse Cardiovascular Events in Moderate-Risk Females: A Statistical and Legal Analysis with Implications for FDA Preemption Claims
This article presents: (1) meta-analyses of studies of cardioprotection of women and men by statins, including Lipitor (atorvastatin), and (2) a legal analysis of advertising promoting Lipitor as preventing heart attacks. The meta-analyses of primary prevention clinical trials show statistically significant benefits for men but not for women, and a statistically significant difference between m...
متن کامل